NO20074874L - Amorf lerkanidipinhydroklorid - Google Patents

Amorf lerkanidipinhydroklorid

Info

Publication number
NO20074874L
NO20074874L NO20074874A NO20074874A NO20074874L NO 20074874 L NO20074874 L NO 20074874L NO 20074874 A NO20074874 A NO 20074874A NO 20074874 A NO20074874 A NO 20074874A NO 20074874 L NO20074874 L NO 20074874L
Authority
NO
Norway
Prior art keywords
amorphous lercanidipine
lercanidipine hydrochloride
approx
substantially pure
pure amorphous
Prior art date
Application number
NO20074874A
Other languages
English (en)
Other versions
NO344559B1 (no
Inventor
Gianni Motta
Amedeo Leonardi
Fabio Berlati
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36585434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074874(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of NO20074874L publication Critical patent/NO20074874L/no
Publication of NO344559B1 publication Critical patent/NO344559B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen tilveiebringer et stort sett rent amorft lerkanidipinhydroklorid som har en renhet på minst 95 %, fortrinnsvis minst ca. 97 %, mer foretrukket minst ca. 99 % og enda mer foretrukket minst ca. 99,5 %. Oppfinnelsen tilveiebringer videre fremgangsmåte for fremstilling av stort sett rent amorft lerkanidipin og farmasøytiske sammensetninger inneholdende det stort sett rene amorfe lerkanidipinet.
NO20074874A 2005-02-25 2007-09-25 Amorf lerkanidipinhydroklorid NO344559B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65683605P 2005-02-25 2005-02-25
PCT/EP2006/001782 WO2006089787A1 (en) 2005-02-25 2006-02-24 Amorphous lercanidipine hydrochloride

Publications (2)

Publication Number Publication Date
NO20074874L true NO20074874L (no) 2007-11-26
NO344559B1 NO344559B1 (no) 2020-02-03

Family

ID=36585434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074874A NO344559B1 (no) 2005-02-25 2007-09-25 Amorf lerkanidipinhydroklorid

Country Status (32)

Country Link
US (1) US7820701B2 (no)
EP (1) EP1856051B1 (no)
JP (1) JP2008531515A (no)
KR (1) KR20070105979A (no)
CN (1) CN101124204A (no)
AR (1) AR052918A1 (no)
AU (1) AU2006218026B9 (no)
BR (1) BRPI0608138A2 (no)
CA (1) CA2598016A1 (no)
CY (1) CY1122429T1 (no)
DK (1) DK1856051T3 (no)
EA (1) EA014383B1 (no)
ES (1) ES2339213T3 (no)
HR (1) HRP20192302T1 (no)
HU (1) HUE046910T2 (no)
IL (1) IL184349A0 (no)
LT (1) LT1856051T (no)
ME (1) ME03659B (no)
MX (1) MX2007010093A (no)
MY (1) MY142129A (no)
NO (1) NO344559B1 (no)
NZ (1) NZ556667A (no)
PE (1) PE20061014A1 (no)
PL (1) PL1856051T3 (no)
PT (1) PT1856051T (no)
RS (1) RS59654B1 (no)
SI (1) SI1856051T1 (no)
TW (1) TW200640861A (no)
UA (1) UA90130C2 (no)
UY (1) UY29401A1 (no)
WO (1) WO2006089787A1 (no)
ZA (1) ZA200708127B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532248B1 (en) 2002-07-26 2009-04-01 Novartis Vaccines and Diagnostics, Inc. Modified small interfering rna molecules and methods of use
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR20080048065A (ko) 2005-09-16 2008-05-30 그렌마크 파머수티칼스 엘티디. 다형 형태의 염산 레르카니디핀 및 이것의 제조방법
DK2046745T3 (da) * 2006-08-04 2014-01-20 Recordati Ireland Ltd Fremgangsmåde til fremstilling af amorft lercanidipin-hydrochlorid
EP2101771A2 (en) * 2006-12-06 2009-09-23 Torrent Pharmaceuticals Ltd Stable lercanidipine formulation
EP2121575A2 (en) * 2007-03-05 2009-11-25 Actavis Group PTC EHF Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
ES2531040T3 (es) * 2009-05-12 2015-03-10 Corcept Therapeutics Inc Formas sólidas y procedimiento de preparación
DE102010005124A1 (de) * 2010-01-19 2012-03-01 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung umfassend Lercanidipin
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法
CN102600146B (zh) * 2012-04-11 2014-10-08 兆科药业（合肥）有限公司 一种盐酸乐卡地平和氯沙坦钾复方制剂及其制备方法
EP3039011A1 (en) * 2013-08-29 2016-07-06 Cadila Healthcare Limited Polymorphic form of pyrrole derivative and intermediate thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
IT1274480B (it) 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
US5912351A (en) 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
US5696139A (en) * 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) * 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011727A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi
US20030069285A1 (en) * 2001-08-06 2003-04-10 Recordati Ireland Limited Novel solvate and crystalline forms of lercanidipine hydrochloride
US20030180355A1 (en) * 2001-10-16 2003-09-25 Amedeo Leonardi Combination therapy for hypertension
JP4749660B2 (ja) * 2002-10-16 2011-08-17 武田薬品工業株式会社 安定な固形製剤
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
US20040198789A1 (en) * 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
TW200616681A (en) 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
KR100651212B1 (ko) 2004-10-27 2006-12-01 제일약품주식회사 무정형 레르카니디핀의 제조방법
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR20080048065A (ko) 2005-09-16 2008-05-30 그렌마크 파머수티칼스 엘티디. 다형 형태의 염산 레르카니디핀 및 이것의 제조방법
EP1963254A2 (en) 2005-09-21 2008-09-03 Torrent Pharmaceuticals Ltd Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
DK2046745T3 (da) 2006-08-04 2014-01-20 Recordati Ireland Ltd Fremgangsmåde til fremstilling af amorft lercanidipin-hydrochlorid

Also Published As

Publication number Publication date
AU2006218026B2 (en) 2009-04-02
PE20061014A1 (es) 2006-10-03
KR20070105979A (ko) 2007-10-31
AU2006218026B9 (en) 2011-10-27
PL1856051T3 (pl) 2020-05-18
US7820701B2 (en) 2010-10-26
NZ556667A (en) 2009-10-30
PT1856051T (pt) 2020-01-07
EP1856051A1 (en) 2007-11-21
RS59654B1 (sr) 2020-01-31
BRPI0608138A2 (pt) 2009-11-17
CN101124204A (zh) 2008-02-13
WO2006089787A1 (en) 2006-08-31
TW200640861A (en) 2006-12-01
LT1856051T (lt) 2020-01-10
IL184349A0 (en) 2007-10-31
ES2339213T3 (es) 2020-05-28
AU2006218026A1 (en) 2006-08-31
HRP20192302T1 (hr) 2020-03-06
EA200701687A1 (ru) 2008-02-28
ME03659B (me) 2021-01-20
JP2008531515A (ja) 2008-08-14
CY1122429T1 (el) 2021-01-27
EA014383B1 (ru) 2010-10-29
EP1856051B1 (en) 2019-11-13
NO344559B1 (no) 2020-02-03
US20060211742A1 (en) 2006-09-21
UA90130C2 (ru) 2010-04-12
UY29401A1 (es) 2006-06-30
ZA200708127B (en) 2008-11-26
DK1856051T3 (da) 2020-01-02
MY142129A (en) 2010-09-30
CA2598016A1 (en) 2006-08-31
HUE046910T2 (hu) 2020-04-28
MX2007010093A (es) 2007-10-12
AR052918A1 (es) 2007-04-11
SI1856051T1 (sl) 2020-02-28
ES2339213T1 (es) 2010-05-18

Similar Documents

Publication Publication Date Title
NO20074874L (no) Amorf lerkanidipinhydroklorid
ATE465719T1 (de) Oral zerfallende zusammensetzung von olanzapin oder donepezil
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
CY1117051T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν κρυσταλλικη μορφη (i) της υδροχλωριουχου λερκανιδιπινης
AP1830A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
NO20092412L (no) Hydantoinderivater anvendes som MMP-inhibitorer
WO2004096128A3 (en) Hiv integrase inhibitors
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20072494L (no) Fast farmasoytisk forbindelse som omfatter donepezil-hydroklorid
NO20052683D0 (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20064344L (no) Caspaseinhibitorer og anvendelser derav
NO20073572L (no) Nye forbindelser
NO20073571L (no) Nye hydantoinderivater som metallproteinaseinhibitorer
NO20071372L (no) Nye polymorfer av azabisykloheksan
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
DK1971216T4 (da) Tyggegummi indeholdende styren-dien-blokcopolymerer
TW200508195A (en) 3-aminopyrrolidines as inhibitors of monoamine uptake
NO20074873L (no) Lerkanidipinfri base
NO20074259L (no) Fremgangsmate for fremstilling av substituerte benzoksazolforbindelser
GEP20094603B (en) NEW ASSOCIATION OF A SINUS CURRENT if INHIBITOR AND A CALCIC INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2005007642A3 (en) Novel azaheterocyclic amides useful for treating pain
TW200716537A (en) Polymorphic form of dexketoprofen trometamol, its preparation and compositions containing it
NO20083521L (no) Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme
MX2008002073A (es) Compuestos para el tratamiento de trastornos inflamatorios.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees